Operating Lease, Right-of-Use Asset of Cullinan Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cullinan Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Cullinan Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,046,000, a 48% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,046,000 -$973,000 -48% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,180,000 -$941,000 -44% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,550,000 -$786,000 -34% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,667,000 -$876,000 -34% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $2,019,000 -$906,000 -31% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,121,000 -$1,380,000 -39% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,336,000 -$1,483,000 -39% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $2,543,000 -$1,587,000 -38% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $2,925,000 -$1,571,000 -35% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $3,501,000 +$2,427,000 +226% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $3,819,000 +$2,625,000 +220% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $4,130,000 +$4,130,000 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $4,496,000 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,074,000 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $1,194,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 09 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.